Seattle Genetics reported $78.09M in Cost of Sales for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US $ 4499M 307M
Acadia Pharmaceuticals ACAD:US $ 5.21M 0.51M
Alexion Pharmaceuticals ALXN:US $ 125.4M 26.8M
Amgen AMGN:US $ 1637M 147M
Astellas Pharma 4503:JP Y 62231M 3904M
Bayer BAYN:GR € 4546M 152M
Biogen BIIB:US $ 511.8M 52.1M
Biomarin Pharmaceutical BMRN:US $ 127.06M 6.9M
Bluebird Bio BLUE:US $ 15.3M 13.02M
Bristol Myers Squibb BMY:US $ 2451M 52M
Clovis Oncology CLVS:US $ 9.64M 0.03M
Daiichi Sankyo 4568:JP Y 85152M 3275M
Eisai 4523:JP Y 39250M 1899M
Eli Lilly And LLY:US $ 1953.2M 74.6M
Esperion Therapeutics ESPR:US $ 1.8M 16K
Exelixis EXEL:US $ 14.88M 1.69M
Gilead Sciences GILD:US $ 1390M 29M
GlaxoSmithKline GSK:LN 2519M 108M
Glaxosmithkline GSK:US $ 2519M 108M
Insmed INSM:US $ 10.84M 993K
Karyopharm Therapeutics KPTI:US $ 1.14M 205K
MacroGenics MGNX:US 22K 5K
Merk MRK:US $ 2684M 771M
Moderna Inc MRNA:US 750M 557M
Nektar Therapeutics NKTR:US $ 7.67M 1.91M
Novartis NOVN:VX SF 3754M 79M
Pfizer PFE:US $ 6992M 2820M
Puma Biotechnology PBYI:US $ 11.97M 17.59M
Regeneron Pharmaceuticals REGN:US $ 693.7M 385.7M
Sarepta Therapeutics SRPT:US $ 19.52M 2.83M
Seattle Genetics SGEN:US $ 78.09M 13.96M
Takeda 4502:JP Y 241264M 12182M
Teva Pharmaceutical TEVA:IT 1.99B 76M
Vertex Pharmaceuticals VRTX:US $ 227.97M 35.64M
YTE INCY:US $ 32.63M 8.81M